EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanopore metagenomic sequencing links clinically relevant resistance determinants to pathogens

Harika Ürel, Ela Sauerborn, Michael Biggel, Friedemann Gebhardt, Ebenezer Foster-Nyarko, Silvio D Brugger, Rhys T White, Søren Heidelbach, Mads Albertsen, Francis Muchaamba, Tim Reska, Marc J A Stevens und 3 weitere

Microbial Genomics · 2026

DOI: 10.1099/mgen.0.001834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Genomics, 2026. Verfasst von Harika Ürel und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Metagenomics, Nanopore Sequencing, Drug Resistance, Bacterial. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Assistant Professorship “One Health with focus on microbial genomics and AI”, Helmholtz Principal Investigator Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Culture-independent metagenomics enables the detection of plasmid-encoded antimicrobial resistance (AMR) genes directly from clinical samples; however, the clinical significance of these genes depends on their bacterial host and genomic context, which metagenomics cannot fully infer. Nanopore sequencing technology intrinsically encodes epigenetic modifications such as methylation, which can be leveraged for plasmid–host associations from metagenomic data. Existing methods rely on the recovery of metagenome-assembled genomes (MAGs), which can introduce bias towards abundant taxa and leave clinically relevant, low-abundance pathogens unassociated. To address this limitation, we extended methylation-based plasmid–host association from the MAG level to individual assembly contigs and sequencing reads. The Contig- and Unassembled-read-based Pathogen Identification and Delineation (CUPID) pipeline implements the calculation of contig and read similarity scores, which compare weighted mean methylation rates across motifs genetically shared between any contig or read pair. We validated this approach on a mock metagenomic community composed of ten carbapenem-resistant Enterobacterales isolates, where we achieved 93.8% accuracy at the contig level and 100% at the read level for carbapenemase plasmid–host associations. When applied to metagenomic and quasimetagenomic data of 16 patient rectal swabs collected during routine hospital surveillance, our approach assigned every detected plasmid-encoded carbapenemase to its correct bacterial host at the contig level, using matched culture-based diagnostics and whole-genome sequencing as the ground truth. Read-level analysis identified additional associations that were missed at the contig level, including a multi-host plasmid confirmed by established diagnostics. These findings demonstrate a pathway from rapid AMR gene detection using metagenomics to actionable surveillance for infection prevention, transmission tracing and outbreak investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetagenomicsNanopore SequencingDrug Resistance, BacterialHumansMetagenomePlasmidsbeta-LactamasesGenome, BacterialAnti-Bacterial AgentsCarbapenemsBacteria

Stichwörter der Autor:innen

antimicrobial resistancemetagenomicsmethylationnanopore sequencingplasmid–pathogen associations

Substanzen

beta-LactamasesAnti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
  • Technical University of Munich School of Life Sciences, Freising, Germany.
  • Helmholtz AI, Helmholtz Zentrum Muenchen, Neuherberg, Germany.
  • Institute of Medical Microbiology, Immunology and Hygiene, Technical University of Munich School of Medicine and Health, Munich, Germany.
  • Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.
  • Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Förderung

  • Assistant Professorship “One Health with focus on microbial genomics and AI”
  • Helmholtz Principal Investigator Grant

Zitieren

APA

Ürel, H., Sauerborn, E., Biggel, M., Gebhardt, F., Foster-Nyarko, E., Brugger, S. D., White, R. T., Heidelbach, S., Albertsen, M., Muchaamba, F., Reska, T., Stevens, M. J. A., Stephan, R., Fetherston, R., & Urban, L. (2026). Nanopore metagenomic sequencing links clinically relevant resistance determinants to pathogens. Microbial Genomics. https://doi.org/10.1099/mgen.0.001834

Vancouver

Ürel H, Sauerborn E, Biggel M, Gebhardt F, Foster-Nyarko E, Brugger SD, et al. Nanopore metagenomic sequencing links clinically relevant resistance determinants to pathogens. Microbial Genomics. 2026. doi:10.1099/mgen.0.001834

BibTeX
@article{rel2026,
  author = {Ürel, Harika and Sauerborn, Ela and Biggel, Michael and Gebhardt, Friedemann and Foster-Nyarko, Ebenezer and Brugger, Silvio D and White, Rhys T and Heidelbach, Søren and Albertsen, Mads and Muchaamba, Francis and Reska, Tim and Stevens, Marc J A and Stephan, Roger and Fetherston, Richard and Urban, Lara},
  title = {Nanopore metagenomic sequencing links clinically relevant resistance determinants to pathogens},
  journal = {Microbial Genomics},
  year = {2026},
  doi = {10.1099/mgen.0.001834}
}
Kostenlos starten →